iNtRON Biotechnology, Inc. (KOSDAQ:048530)

South Korea · Delayed Price · Currency is KRW

2,705.00

-75.00 (-2.70%)

Aug 12, 2026, 1:44 PM KST

iNtRON Biotechnology Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,740	5,740	6,418	9,585	14,007	29,308
Revenue Growth	-10.56%	-10.56%	-33.05%	-31.57%	-52.21%	-35.49%
Gross Profit	3,045	3,045	3,679	5,783	9,595	21,694
Operating Income	-7,904	-7,904	-5,238	-3,285	-1,479	10,077
Net Income	-8,958	-8,958	-2,591	-9,695	5,712	9,728
Earnings Per Share	-282.94	-282.94	-79.00	-292.11	-0.34	288.00
EPS Growth	-	-	-	-	-	-25.98%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	41,775	41,775	49,843	57,184	108,351	113,497
Total Debt	3,354	3,354	1,245	402.91	31,271	45,756
Net Cash (Debt)	38,422	38,422	48,598	56,781	77,080	67,741
Net Cash Growth	-20.94%	-20.94%	-14.41%	-26.33%	13.79%	21.22%
Net Cash Per Share	1213.51	1213.51	1481.68	1710.73	2272.18	2008.38

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-5,209	-5,209	-138.47	3,118	5,977	16,473
Capital Expenditures	-2,470	-2,470	-1,122	-7,791	-2,229	-3,046
Free Cash Flow	-7,679	-7,679	-1,260	-4,673	3,748	13,427
Free Cash Flow Growth	-	-	-	-	-72.08%	489.12%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	53.05%	53.05%	57.33%	60.33%	68.51%	74.02%
Operating Margin	-137.69%	-137.69%	-81.61%	-34.27%	-10.56%	34.38%
Pretax Margin	-157.37%	-157.37%	-46.84%	-113.06%	59.39%	36.08%
Profit Margin	-156.06%	-156.06%	-40.37%	-101.15%	40.78%	33.19%
FCF Margin	-133.77%	-133.77%	-19.64%	-48.75%	26.76%	45.81%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	47.25	72.99
Forward PE	-	105.99	105.99	105.99	105.99	105.99
P/FCF Ratio	-	-	-	-	72.00	52.88
PS Ratio	14.96	17.90	28.60	30.40	19.27	24.23